Login / Signup

LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy.

Lingjuan SunZhibo MaXiangli ZhaoXiaosheng TanYuhao TuJingzeng WangLi ChenZhishui ChenGang ChenPeixiang Lan
Published in: Journal for immunotherapy of cancer (2024)
LRP11-MAPK13-TCF1 enhanced antitumor immunity and induced tumor-infiltrating stem-like T cells.
Keyphrases
  • signaling pathway
  • oxidative stress
  • pi k akt
  • diabetic rats
  • high glucose
  • low density lipoprotein
  • drug induced
  • protein kinase